ProtoKinetix Inc.: Worldwide Synthetic AFGP Patent Process Begins
October 27, 2004 09:15 ET
|
ProtoKinetix, Incorporated
VANCOUVER, British Columbia, Oct. 27, 2004 (PRIMEZONE) -- Dr. John Todd, president and CEO of ProtoKinetix, Inc. (OTCBB:PKTX), announces today that the Company's synthetic Anti-Freeze Glyco Proteins...
ProtoKinetix: Third Party Evaluation Trials Convince Scientific Advisory Board
October 14, 2004 13:59 ET
|
ProtoKinetix, Incorporated
VANCOUVER, British Columbia, Oct. 14, 2004 (PRIMEZONE) -- ProtoKinetix, Inc.'s (OTCBB:PKTX) Director of Medical Research, Dr. Jean-Marie Dupuis, announces today from Paris that the independent...
ProtoKinetix Completes Acquisition of Synthetic AFGP Technology
September 08, 2004 11:52 ET
|
ProtoKinetix, Incorporated
VANCOUVER, British Columbia, Sept. 8, 2004 (PRIMEZONE) -- ProtoKinetix (OTCBB:PKTX) is pleased to announce the acquisition of a world-wide, exclusive license to produce and market synthetic...
ProtoKinetix Reports on Potential of AFGP as Well as Progress Made on the AFGP Transaction
July 15, 2004 15:07 ET
|
ProtoKinetix, Incorporated
VANCOUVER, British Columbia, July 15, 2004 (PRIMEZONE) -- On June 28, 2004, ProtoKinetix (OTCBB:PKTX) announced that it had reached an agreement with Perigene, Inc. to acquire a patented antifreeze...
Jean-Louis Boitieux, Ph.D. Takes Seat On ProtoKinetix Scientific Advisory Board
July 01, 2004 09:15 ET
|
ProtoKinetix, Incorporated
VANCOUVER, British Columbia, July 1, 2004 (PRIMEZONE) -- Dr. John Todd, President of ProtoKinetix, Inc. (OTCBB:PKTX) is indeed privileged to announce Professor Jean-Louis Boitieux's acceptance of a...
ProtoKinetix Acquires AFGP Technology From Perigene, Inc.
June 28, 2004 09:15 ET
|
ProtoKinetix, Incorporated
VANCOUVER, British Columbia, June 28, 2004 (PRIMEZONE) -- Dr. John Todd, President and CEO of ProtoKinetix, Inc. (OTCBB:PKTX) announced today that the company has entered into an agreement to...
ProtoKinetix Receives First Monoclonal Antibody
June 10, 2004 11:27 ET
|
ProtoKinetix, Incorporated
VANCOUVER, British Columbia, June 10, 2004 (PRIMEZONE) -- ProtoKinetix, Inc. (OTCBB:PKTX) is pleased to announce that it has received its first antibody from BioCurex. This is a monoclonal antibody...
Trial Results Are Significant Breakthrough For ProtoKinetix
June 01, 2004 11:20 ET
|
ProtoKinetix, Incorporated
VANCOUVER, British Columbia, June 1, 2004 (PRIMEZONE) -- Dr. John Todd, President and CEO of ProtoKinetix (OTCBB:PKTX), states, "Confirmation by the Georges Pompidou Hospital that a clear binding of...
ProtoKinetix Inc.: Georges Pompidou Hospital Reports Clear Labelling of Malignant Cells
May 20, 2004 09:15 ET
|
ProtoKinetix, Incorporated
VANCOUVER, British Columbia, May 20, 2004 (PRIMEZONE) -- ProtoKinetix Inc. (OTCBB:PKTX) announces today that it has received a report from the Georges Pompidou Hospital in Paris on the first 40...
Jean-Charles Quirion, Ph.D. Accepts Position on ProtoKinetix Scientific Advisory Board
May 10, 2004 09:15 ET
|
ProtoKinetix, Incorporated
VANCOUVER, British Columbia, Canada, May 10, 2004 (PRIMEZONE) -- Dr. John Todd, President of ProtoKinetix, Inc. (OTCBB:PKTX) is honored to announce today that Jean-Charles Quirion has agreed to serve...